{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:52:37Z","timestamp":1790689957542,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006978","name":"University of California Berkeley","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006978","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jlr.2023.100339","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T21:29:46Z","timestamp":1675286986000},"page":"100339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Acetyl-CoA carboxylase inhibitor increases LDL-apoB production rate in NASH with cirrhosis: prevention by fenofibrate"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3751-8968","authenticated-orcid":false,"given":"Mohamad","family":"Dandan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4970-1073","authenticated-orcid":false,"given":"Sabrina","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9521-3177","authenticated-orcid":false,"given":"Rachael","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Chieh","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N.","family":"Billin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Huss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuhan","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2327-0834","authenticated-orcid":false,"given":"Marc","family":"Hellerstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2023.100339_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00004836-200203000-00013","article-title":"Update on nonalcoholic fatty liver disease","volume":"34","author":"McCullough","year":"2002","journal-title":"J.\u00a0Clin. Gastroenterol."},{"key":"10.1016\/j.jlr.2023.100339_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cld.2017.08.003","article-title":"The natural history of Nonalcoholic Fatty Liver Disease-an evolving view","volume":"22","author":"Lindenmeyer","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.jlr.2023.100339_bib3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cld.2015.10.010","article-title":"Progression and natural history of Nonalcoholic Fatty Liver Disease in adults","volume":"20","author":"Marengo","year":"2016","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.jlr.2023.100339_bib4","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2023.100339_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0032-1306423","article-title":"Dyslipidemia in patients with nonalcoholic fatty liver disease","volume":"32","author":"Chatrath","year":"2012","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jlr.2023.100339_bib6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1476-511X-13-100","article-title":"Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile","volume":"13","author":"Corey","year":"2014","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.jlr.2023.100339_bib7","first-page":"1","article-title":"Lipoprotein metabolism in nonalcoholic fatty liver disease","volume":"27","author":"Jiang","year":"2013","journal-title":"J.\u00a0Biomed. Res."},{"key":"10.1016\/j.jlr.2023.100339_bib8","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cmet.2017.07.009","article-title":"Acetyl CoA carboxylase inhibition reduces hepatic steatosis but elevates plasma triglycerides in mice and humans: a bedside to bench investigation","volume":"26","author":"Kim","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2023.100339_bib9","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/jcb.21077","article-title":"Acetyl-coenzyme A carboxylases: versatile targets for drug discovery","volume":"99","author":"Tong","year":"2006","journal-title":"J.\u00a0Cell Biochem."},{"key":"10.1016\/j.jlr.2023.100339_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/13543784.2020.1668374","article-title":"GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)","volume":"29","author":"Alkhouri","year":"2020","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.jlr.2023.100339_bib11","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/hep.30097","article-title":"Acetyl-CoA carboxylase inhibition reverses NAFLD and hepatic insulin resistance but promotes hypertriglyceridemia in rodents","volume":"68","author":"Goedeke","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2023.100339_bib12","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.cgh.2018.04.042","article-title":"Acetyl-CoA carboxylase inhibitor GS-0976 for 12 weeks reduces hepatic de novo lipogenesis and steatosis in patients with nonalcoholic steatohepatitis","volume":"16","author":"Lawitz","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jlr.2023.100339_bib13","article-title":"Fenofibrate mitigates hypertriglyceridemia in nonalcoholic steatohepatitis patients treated with Cilofexor\/Firsocostat","author":"Lawitz","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jlr.2023.100339_bib14","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1053\/j.gastro.2018.07.027","article-title":"GS-0976 reduces hepatic steatosis and fibrosis markers in patients with Nonalcoholic Fatty Liver Disease","volume":"155","author":"Loomba","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jlr.2023.100339_bib15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/hep.31622","article-title":"Combination therapies including cilofexor and firsocostat for bridging fibrosis and cirrhosis attributable to NASH","volume":"73","author":"Loomba","year":"2021","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.jlr.2023.100339_bib16","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/s41591-021-01489-1","article-title":"ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials","volume":"27","author":"Calle","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.jlr.2023.100339_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1172\/JCI108764","article-title":"A\u00a0possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis","volume":"60","author":"McGarry","year":"1977","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jlr.2023.100339_bib18","series-title":"Biochemistry of Lipids, Lipoproteins, and Membranes","author":"Vance","year":"2008"},{"key":"10.1016\/j.jlr.2023.100339_bib19","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0022-2275(20)38425-X","article-title":"Plasma very low-density lipoproteins contain a single molecule of apolipoprotein B","volume":"29","author":"Elovson","year":"1988","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2023.100339_bib20","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1172\/JCI112010","article-title":"Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease","volume":"76","author":"Kes\u00e4niemi","year":"1985","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jlr.2023.100339_bib21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1172\/JCI114507","article-title":"Measurement of very low density and low-density lipoprotein apolipoprotein (Apo) B-100 and high-density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding","volume":"85","author":"Cohn","year":"1990","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jlr.2023.100339_bib22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1194\/jlr.M300309-JLR200","article-title":"Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia","volume":"45","author":"Bilz","year":"2004","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2023.100339_bib23","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1161\/01.ATV.0000172629.12846.b8","article-title":"TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status","volume":"25","author":"Matthan","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2023.100339_bib24","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bbagen.2005.12.023","article-title":"Measurement of protein turnover rates by heavy water labeling of nonessential amino acids","volume":"1760","author":"Busch","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jlr.2023.100339_bib25","series-title":"Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease","article-title":"Isotopic tracers for the measurement of metabolic flux rates","author":"Beysen","year":"2019"},{"key":"10.1016\/j.jlr.2023.100339_bib26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/bs.mie.2015.05.018","article-title":"Dynamic proteomics: in\u00a0vivo proteome-wide measurement of protein kinetics using metabolic labeling","volume":"561","author":"Holmes","year":"2015","journal-title":"Met. Enzymol."},{"key":"10.1016\/j.jlr.2023.100339_bib27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0022-2275(20)40262-7","article-title":"Analysis of low-density lipoproteins by preparative ultracentrifugation and refractometry","volume":"5","author":"Lindgren","year":"1964","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2023.100339_bib28","first-page":"E1146","article-title":"Mass isotopomer distribution analysis at eight years: theoretical, analytic, and experimental considerations","volume":"276","author":"Hellerstein","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jlr.2023.100339_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ab.2011.09.007","article-title":"Measurement of human plasma proteome dynamics with (2)H(2)O and liquid chromatography tandem mass spectrometry","volume":"420","author":"Price","year":"2012","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jlr.2023.100339_bib30","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1161\/01.ATV.19.12.2966","article-title":"Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes","volume":"19","author":"Welty","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2023.100339_bib31","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","year":"2019","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.jlr.2023.100339_bib32","doi-asserted-by":"crossref","first-page":"E1796","DOI":"10.1073\/pnas.1520686113","article-title":"Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats","volume":"113","author":"Harriman","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2023.100339_bib33","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/hep.30206","article-title":"Trimming the fat: Acetyl-CoA carboxylase inhibition for the management of NAFLD","volume":"68","author":"Imai","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2023.100339_bib34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.tem.2013.04.001","article-title":"The regulation of ApoB metabolism by insulin","volume":"24","author":"Haas","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jlr.2023.100339_bib35","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1210\/jcem.86.3.7304","article-title":"Clinical review 124: diabetic dyslipidemia: causes and consequences","volume":"86","author":"Goldberg","year":"2001","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jlr.2023.100339_bib36","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/ATVBAHA.111.241463","article-title":"Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia","volume":"32","author":"Sparks","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2023.100339_bib37","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrendo.2017.91","article-title":"SREBP-regulated lipid metabolism: convergent physiology \u2014 divergent pathophysiology","volume":"13","author":"Shimano","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jlr.2023.100339_bib38","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2337\/diabetes.52.3.803","article-title":"Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome","volume":"52","author":"Watts","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.jlr.2023.100339_bib39","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1161\/01.ATV.13.5.702","article-title":"Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia","volume":"13","author":"Caslake","year":"1993","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.jlr.2023.100339_bib40","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1210\/jc.2009-2622","article-title":"Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease","volume":"95","author":"Fabbrini","year":"2010","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jlr.2023.100339_bib41","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1053\/jhep.2002.32527","article-title":"Apolipoprotein synthesis in nonalcoholic steatohepatitis","volume":"35","author":"Charlton","year":"2002","journal-title":"Hepatol. (Baltimore, Md"},{"key":"10.1016\/j.jlr.2023.100339_bib42","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jcmgh.2020.06.001","article-title":"Acetyl-CoA carboxylase inhibition improves multiple dimensions of NASH pathogenesis in model systems","volume":"10","author":"Ross","year":"2020","journal-title":"Cell Mol. Gastroenterol. Hepatol."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227523000123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227523000123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T18:32:37Z","timestamp":1758306757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227523000123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0022227523000123"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2023.100339","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetyl-CoA carboxylase inhibitor increases LDL-apoB production rate in NASH with cirrhosis: prevention by fenofibrate","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2023.100339","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100339"}}